◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › T › TCMD

Tactile Systems Technology Inc (TCMD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-10-02

Tactile Systems Technology Inc (TCMD) operates in the MEDICAL DEVICES industry and is headquartered in Minneapolis, United States with about 1,086 employees. Its market capitalization is roughly $561 million. In the fiscal year ended 2025-12-31, TCMD reported $330M in revenue and $19M in net income.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

Interactive charts & full statements → Open the TCMD valuation workbench →

TCMD Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Total Revenue$350M$330M$293M$274M$247M$208M$187M$189M$144M$109M$85M$63M$48M$37M
Gross Profit$260M$248M$217M$195M$176M$148M$133M$134M$102M$80M$62M$46M$35M$27M
Gross Margin %74.2%75.2%74.0%71.1%71.3%71.2%71.0%70.8%71.1%73.5%72.9%73.1%73.4%73.7%
Operating Income (EBIT)$35M$29M$22M$18M($13M)($2M)($4M)$10M$3M$4M$4M$3M$4M$2M
Operating Margin %10.0%8.9%7.6%6.6%-5.2%-0.9%-1.9%5.5%2.1%3.6%5.1%5.5%8.0%6.4%
Net Income$25M$19M$17M$29M($18M)($12M)($1M)$11M$7M$6M$3M$1M$2M$3M
Net Margin %7.1%5.8%5.8%10.4%-7.2%-5.7%-0.3%5.8%4.6%5.4%3.4%2.2%4.3%8.5%
EBITDA$44M$39M$32M$26M$2M$1M($1M)$14M$3M$4M$5M$4M$5M$3M
Earnings Per Share (EPS)$1.09$0.82$0.70$1.23$-0.89$-0.60$-0.03$0.56$0.34$0.31$0.17$0.10$0.16$1.32
Shares Outstanding (M)23M23M24M23M20M20M19M20M19M19M17M13M13M2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TCMD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$86M$75M$104M$86M$79M$61M$86M$73M
Gross Profit$59M$58M$79M$65M$59M$45M$64M$54M
Gross Margin %68.7%76.5%75.8%75.8%74.5%74.0%75.2%74.1%
Operating Income (EBIT)$7M($2M)$19M$11M$4M($5M)$13M$7M
Operating Margin %8.0%-2.0%18.1%12.8%5.2%-7.4%14.6%9.3%
Net Income$8M($2M)$11M$8M$3M($3M)$10M$5M
Net Margin %9.1%-2.3%10.3%9.6%4.1%-4.9%11.3%7.0%
EBITDA$9M$1M$21M$13M$7M($2M)$18M$9M
Earnings Per Share (EPS)$0.34$-0.08$0.46$0.36$0.14$-0.13$0.40$0.21
Shares Outstanding (M)23M23M23M23M23M24M24M24M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TCMD Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Cash from Operations (CFO)$31M$43M$41M$36M$5M$3M$3M$3M$9M$4M$7M$1M($1M)$0M
Capital Expenditures (CapEx)$4M$2M$3M$2M$2M$2M$2M$6M$10M$4M$1M$1M$0M$0M
Free Cash Flow (FCF)$27M$40M$38M$33M$3M$0M$1M($3M)($1M)$0M$6M$1M($1M)($1M)
FCF Margin %7.6%12.3%13.0%12.2%1.3%0.1%0.3%-1.8%-0.4%0.3%7.3%1.2%-2.8%-2.1%
Dividends Paid———$8M$1M$61M——$0M$0M$8M$8M$8M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TCMD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$3M$0M$17M$10M$15M$0M$16M$10M
Capital Expenditures (CapEx)$1M$1M$1M$1M$0M$0M$0M$1M
Free Cash Flow (FCF)$2M($1M)$17M$9M$14M$0M$16M$9M
FCF Margin %2.3%-1.6%16.1%10.7%18.2%0.0%18.5%12.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TCMD Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Total Assets$280M$274M$298M$281M$255M$244M$174M$152M$107M$88M$74M$37M$31M$29M
Cash & Cash Equivalents$70M$83M$94M$61M$22M$28M$48M$23M$20M$24M$31M$7M$5M$7M
Total Liabilities$56M$55M$81M$88M$134M$116M$49M$39M$18M$16M$14M$10M$7M$7M
Total Debt (Short + Long-Term)$3M$3M$29M$32M$51M$57M$2M$1M$0M$0M$0M$1M$0M$0M
Total Shareholders' Equity$224M$219M$217M$194M$121M$128M$125M$113M$89M$73M$60M$27M$25M$22M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TCMD viewer.

Other Companies in MEDICAL DEVICES

← TCMCAll “T” companiesTCOAT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.